Preventive treatments for breast cancer: recent developments
Resumen: Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. Recent developments in the armamentarium of effective drugs for breast cancer prevention (namely exemestane and anastrozole), the new recommendation from the National Institute for Health and Care Excellence to use preventative drugs in women at high risk as well as updated Guidelines from the US Preventive Services Task Force and the American Society of Clinical Oncology should give renewed momentum to the pharmacological prevention of breast cancer. In this article we review recent major developments in the field and examine their ongoing repercussion for breast cancer prevention. As a practical example, the potential impact of preventive measures in Spain is evaluated and a course of practical actions is delineated.
Idioma: Inglés
DOI: 10.1007/s12094-014-1250-2
Año: 2015
Publicado en: Clinical and Translational Oncology 17, 4 (2015), 257-263
ISSN: 1699-048X

Factor impacto JCR: 2.075 (2015)
Categ. JCR: ONCOLOGY rank: 153 / 213 = 0.718 (2015) - Q3 - T3
Factor impacto SCIMAGO: 0.865 - Medicine (miscellaneous) (Q2) - Oncology (Q2) - Cancer Research (Q3)

Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Exportado de SIDERAL (2021-01-21-10:52:00)

Este artículo se encuentra en las siguientes colecciones:

 Record created 2016-12-21, last modified 2021-01-21

Versión publicada:
Rate this document:

Rate this document:
(Not yet reviewed)